Ambitious companies can unlock International R&D Incentives across multiple countries to accelerate research and commercialisation while preserving cash. This guide explains how to structure cross-border projects, avoid double funding, and optimise claims in 2025.
What are International R&D Incentives?
International R&D incentives are government supports that reduce the net cost of innovation, typically through tax credits, allowances or grants. Across the OECD, tax incentives now outpace direct grants as the dominant form of support, with the majority of jurisdictions offering relief.
Why does this matter for cross-border teams? Multinational groups often run R&D in several locations, combining local tax incentives with EU or national grants. The opportunity is material, yet rules on territoriality, subcontracting and no double funding for the same cost require careful design.
How it works across borders, a practical 7-step playbook
- Map the work by location. List which legal entities and countries will perform each work package, and confirm territorial rules for claiming.
- Choose the right instrument per country. Many markets rely on R&D tax credits, while grants are used for strategic missions. Start broad, then drill down into local rules.
- Check subcontracting and overseas spend. Some regimes cap or restrict R&D done outside the country. Plan early where foreign labs or contractors are needed.
- Avoid double dipping. The same cost should not be subsidised twice. Decide whether a cost sits in a grant budget or in a tax claim, not both.
- Align with transfer pricing. Intercompany recharges must reflect substance, documentation and the entity that benefits from the R&D.
- Sequence claims and filings. Grants have competition deadlines, while tax incentives follow fiscal calendars. Build a combined timetable per entity.
- Evidence the science. Keep technical narratives, time records and cost trails that local reviewers recognise. Aim for consistent, country-specific documentation sets.
Eligibility at a glance
Common themes
- The claimant is usually a company in the jurisdiction that incurs qualifying R&D costs.
- Eligible R&D involves resolving scientific or technological uncertainty, with personnel costs typically core.
- Subcontracting and externally provided workers are often allowed with limits, especially for work undertaken overseas.
SME versus large enterprise
- SMEs often access higher effective benefits or simplified pathways.
- Large enterprises can claim, but should expect tighter documentation and sometimes lower headline rates.
Funding scope and benefits
Most regimes recognise salary costs for researchers, consumables, software and some subcontracted R&D. Many also allow prototyping and testing. Grants may add capital items or testbeds where strategically important. The right mix can improve runway without equity dilution while keeping IP and talent near markets.
Market context in 2025
Tax incentives have expanded across advanced economies. For cross-border programmes this means more options, but also more variation to navigate. The key is to anchor decisions in commercial needs and apply the right instrument per jurisdiction.
Country snapshots and compliance notes
United Kingdom
- Regime. A merged RDEC-style scheme applies to periods beginning on or after 1 April 2024, alongside Enhanced R&D Intensive Support (ERIS) for qualifying loss-making SMEs.
- Overseas work. Rules restrict relief for overseas R&D with narrow exceptions, and updated guidance applies to contracted-out R&D. Plan carefully if using foreign labs or contractors.
- What good looks like. Clear UK nexus, strong evidence packs, and early decision on whether costs sit in grants or the tax claim.
France
- Regime. Crédit d’Impôt Recherche (CIR) remains a flagship tax credit for R&D, with periodic doctrine updates clarifying eligible expenses.
- Cross-border note. Subcontracted R&D rules depend on the type of provider and location. Confirm current guidance before allocating work packages.
Germany
- Regime. Forschungszulage is a volume-based research allowance. Recent reforms increased the SME rate and broadened the base, with higher caps.
- Cross-border note. Contract research and group structures can qualify within defined limits. Maintain robust documentation and contracts.
Spain
- Regime. Corporate tax offers deductions for I+D+i with distinct treatment for R&D versus technological innovation and defined eligible cost categories.
- Cross-border note. Consider monetisation options and limitations where there is insufficient tax to absorb credits.
Italy
- Regime. A multi-track credito d’imposta covers R&D, technological innovation, design and aesthetic conception, with oversight arrangements updated in 2025.
- Cross-border note. Projects must be qualified under current MIMIT guidelines to ensure eligibility across sites.
According to consultancy FI Group, international claim strategies perform best when the commercial plan drives the location of work, not the incentive rate alone. Teams that map work packages, decide early on grant versus tax treatment, and standardise documentation across entities reduce audit risk and improve certainty. For practical steps, see FI Group’s funding advisers’ guidance.
Application process, coordination checklist
- Set governance. Name a global incentives lead with local finance and technical owners per country.
- Fix your calendar. Combine grant cut-offs with tax filing and notification dates per jurisdiction.
- Standardise evidence. Use a common template for technical narratives, time writing and subcontractor statements.
- Decide on cost routing. Allocate each task either to a grant budget or to a tax claim ledger code.
- Review IP and transfer pricing. Check that development and ownership align with incentives and value creation.
- Run a red-team review. Validate eligibility narratives against official guidance before filing.
Common CFO challenges and how to mitigate
- Double funding risk. Maintain a single source of truth for costs, with controls to prevent overlap between grants and tax claims.
- Overseas restrictions. Build decision trees for when foreign work qualifies and document exceptions.
- Documentation gaps. Time writing and subcontract evidence are frequent weak points.
- Cashflow timing. Layer predictable tax incentives with milestone-based grants to smooth inflows.
- Group complexity. Align transfer pricing, beneficial owner of IP, and claimant entity to avoid clawbacks.
FAQs
1) Can we claim in more than one country for the same R&D?
Yes, but not for the same cost. Different entities can claim their own eligible costs in their own jurisdictions. Avoid double funding of the same expenditure across instruments.
2) Do most countries allow subcontracted R&D?
Many do, with limits and special rules for overseas work. Always check the latest local guidance per jurisdiction.
3) Which is better, grants or tax incentives?
Grants provide upfront support for targeted missions, while tax incentives provide broad and predictable relief. Most cross-border programmes use a mix, sequenced by TRL and cash needs.
4) How do global trends affect planning?
With many jurisdictions offering tax relief and incentives expanding, location choices and compliance planning matter more than ever for multinationals.
5) Can UK companies still benefit after regime changes?
Yes. The merged scheme and ERIS remain available, but claim mechanics and overseas rules changed from April 2024. Plan early and document thoroughly.